Financials data is unavailable for this security.
View more
Year on year Cementos Bio Bio SA grew revenues 4.49% from 334.00bn to 348.98bn. In addition the company has reduced the cost of goods sold as a percent of sales, selling, general and administrative expenses as a percent of sales and interest paid as a percent of sales. These improvements contributed to 115.88% net income growth from 10.56bn to 22.80bn.
| Gross margin | 38.79% |
|---|---|
| Net profit margin | 9.12% |
| Operating margin | 14.29% |
| Return on assets | 6.69% |
|---|---|
| Return on equity | 12.62% |
| Return on investment | 8.21% |
More ▼
Cash flow in CLPView more
In 2023, Cementos Bio Bio SA increased its cash reserves by 27.60%, or 2.95bn. The company earned 41.44bn from its operations for a Cash Flow Margin of 11.87%. In addition the company used 17.41bn on investing activities and also paid 21.13bn in financing cash flows.
| Cash flow per share | 231.31 |
|---|---|
| Price/Cash flow per share | 3.02 |
| Book value per share | 1,036.39 |
|---|---|
| Tangible book value per share | 965.92 |
More ▼
Balance sheet in CLPView more
| Current ratio | 1.59 |
|---|---|
| Quick ratio | 0.9434 |
| Total debt/total equity | 0.4809 |
|---|---|
| Total debt/total capital | 0.3242 |
More ▼
Growth rates in CLP
Year on year, growth in dividends per share fell -73.68% while earnings per share excluding extraordinary items rose 115.88%. Additionally when measured on a five year annualized basis, dividend per share growth is in-line with the industry average relative to its peers, while earnings per share growth is the highest in its industry.
| Div yield(5 year avg) | 8.46% |
|---|---|
| Div growth rate (5 year) | -15.20% |
| Payout ratio (TTM) | 28.91% |
| EPS growth(5 years) | 2.89 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 104.56 |
More ▼
